Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: neuroscience – Page 70

Inflammation may be the link between chronic pain and depression

Chronic pain—or pain that lasts at least three months—is closely intertwined with depression. Individuals living with pain’s persistent symptoms may be up to four times more likely to experience depression, research shows.

Almost 30% of people worldwide suffer from a chronic pain condition such as and migraines, and one in three of these patients also report co-existing pain conditions.

Now, a new study published in Science Advances shows that a person’s risk of depression increases alongside the number of places in the body in which they experience pain. Furthermore, inflammatory markers such as C-reactive protein (a protein produced by the liver in response to inflammation) help explain the association between pain and depression.

Key Enzyme Links Inflammation to Memory Loss in Alzheimer’s

A research team at the Institute for Basic Science (IBS) has identified a previously unknown enzyme, SIRT2, that plays a key role in memory loss associated with Alzheimer’s disease (AD). The study, led by Director C Justin LEE, of the IBS Center for Cognition and Sociality, provides critical insights into how astrocytes contribute to cognitive decline by producing excessive amounts of the inhibitory neurotransmitter GABA.

Astrocytes, once thought to only support neurons, are now known to actively influence brain function. In Alzheimer’s disease, astrocytes become reactive, meaning they change their behavior in response to the presence of amyloid-beta (Aβ) plaques, a hallmark of the disease. While astrocytes attempt to clear these plaques, this process triggers a harmful chain reaction. First, they uptake them via autophagy (Kim and Chun, 2024) and degrade them by the urea cycle (Ju et al, 2022), as discovered in previous research. However, this breakdown results in the overproduction of GABA, which dampens brain activity and leads to memory impairment. Additionally, this pathway generates hydrogen peroxide (H2O2), a toxic byproduct that causes further neuronal death and neurodegeneration.

Scientists discover the protein IL-17 that fights infection also acts on the brain, inducing anxiety or sociability

Immune molecules called cytokines play important roles in the body’s defense against infection, helping to control inflammation and coordinating the responses of other immune cells. A growing body of evidence suggests that some of these molecules also influence the brain, leading to behavioral changes during illness.

Two new studies from MIT and Harvard Medical School, focusing on a cytokine called IL-17, now add to that evidence. The researchers found that IL-17 acts on two distinct brain regions—the amygdala and the somatosensory cortex—to exert two divergent effects. In the amygdala, IL-17 can elicit feelings of anxiety, while in the cortex it promotes sociable behavior.

These findings suggest that the immune and nervous systems are tightly interconnected, says Gloria Choi, an associate professor of brain and cognitive sciences, a member of MIT’s Picower Institute for Learning and Memory, and one of the senior authors of the studies.

Study may explain how infections reduce autism symptoms

For many years, some parents have noticed that their autistic children’s behavioral symptoms diminished when they had a fever. This phenomenon has been documented in at least two large-scale studies over the past 15 years, but it was unclear why fever would have such an effect.

A new study from MIT and Harvard Medical School sheds light on the cellular mechanisms that may underlie this phenomenon. In a study of , the researchers found that in some cases of infection, an immune molecule called IL-17a is released and suppresses a small region of the brain’s cortex that has previously been linked to social behavioral deficits in mice.

“People have seen this phenomenon before [in people with autism], but it’s the kind of story that is hard to believe, which I think stems from the fact that we did not know the mechanism,” says Gloria Choi, the Samuel A. Goldblith Career Development Assistant Professor of Applied Biology and an assistant professor of brain and cognitive sciences at MIT. “Now the field, including my lab, is trying hard to show how this works, all the way from the and molecules to receptors in the brain, and how those interactions lead to behavioral changes.”

Abstract: Another reason to sleep!

Geoffrey Canet et al. discover wakefulness body temperature upregulates neuronal tau secretion and correlates with tau levels, highlighting the importance of sleep and thermoregulation in Alzheimer’s disease:

The figure shows temperature-dependent increase of colocalization between SDC3 (purple) and TauC3 (yellow) in primary mouse cortical neurons.

1Centre de Recherche du CHU de Québec – Université Laval, Axe Neurosciences, Québec, Québec City, Canada.

2Université Laval, Faculté de Médecine, Département de Psychiatrie et Neurosciences, Québec, Québec City, Canada.

3Université Laval, Faculté de Médecine, Département de Médecine Moléculaire, Québec, Québec City, Canada.

Microscale brain–computer interface is small enough to be placed between hair follicles

A team of engineers at Georgia Institute of Technology’s Wearable Intelligent Systems and Healthcare Center, working with colleagues affiliated with several institutions in South Korea, has developed a microscale brain–computer interface that is small enough to be placed between hair follicles on a user’s head.

In their paper published in the Proceedings of the National Academy of Sciences, the group describes how they made their interface, how it attaches to other hardware to allow readings to be captured and how well it worked during testing.

Over the past several decades, brain–computer interfaces have been developed that are capable of reading brain waves and responding to them in useful ways. These devices can be used to control a cursor on a computer screen, for example, or to choose buttons to press. Such devices are still in limited use, however, mainly due to their bulky nature. In this new effort, the researchers have developed a sensor so small it can be placed on the scalp between hair follicles.

Santiago Ramón y Cajal

(Spanish: [sanˈtjaɣo raˈmon i kaˈxal] ; 1 May 1852 – 17 October 1934) [ 1 ] [ 2 ] was a Spanish neuroscientist, pathologist, and histologist specializing in neuroanatomy and the central nervous system. He and Camillo Golgi received the Nobel Prize in Physiology or Medicine in 1906. [ 3 ] Ramón y Cajal was the first Spaniard to win a scientific Nobel Prize. His original investigations of the microscopic structure of the brain made him a pioneer of modern neuroscience.